Abstract: The present disclosure relates to methods for reducing the rate of cardiovascular death, myocardial infarction, or stroke in a patient in recognized need thereof, comprising administering to the patient a pharmaceutical composition comprising 60 mg ticagrelor twice daily.

Abstract: The present disclosure relates to methods for reducing the rate of cardiovascular death, myocardial infarction, or stroke in a patient in recognized need thereof, comprising administering to the patient a pharmaceutical composition comprising 60 mg ticagrelor twice daily.

Abstract: A method for controlling a speed of a machine is disclosed. The machine may have a controller in communication with an operator interface and a hydraulic system configured to control tracks of the machine. The method may include the controller setting a current value for a speed limit on the machine according to a first predetermined value; the controller providing a display on the operator interface indicating the current value of the speed limit, the current value being the first predetermined value; the controller receiving input from the operator interface to change the speed limit to a second value; the controller setting the current value for the speed limit on the machine according to the second value; and the controller changing the display to indicate the current value of the speed limit being the second value.

Abstract: A method for controlling a speed of a machine is disclosed. The machine may have a controller in communication with an operator interface and a hydraulic system configured to control tracks of the machine. The method may include the controller setting a current value for a speed limit on the machine according to a first predetermined value; the controller providing a display on the operator interface indicating the current value of the speed limit, the current value being the first predetermined value; the controller receiving input from the operator interface to change the speed limit to a second value; the controller setting the current value for the speed limit on the machine according to the second value; and the controller changing the display to indicate the current value of the speed limit being the second value.

Abstract: An electrolysis system adapted to split water into hydrogen and oxygen gases includes a housing, a baffle dividing the housing into first and second chambers and including an upper solid portion and a lower portion, a first electrode disposed in the first chamber, and a second electrode disposed in the second chamber. The first and second electrodes are configured to be at least partially immersed in the water, and each electrode becomes electrically charged when the electrolysis system is coupled to a current source to split the water into hydrogen and oxygen gases. The lower portion of the baffle and the first and second electrodes are each formed from the same material.

Abstract: An electrolysis system adapted to split water into hydrogen and oxygen gases includes a housing, a baffle dividing the housing into first and second chambers and including an upper solid portion and a lower portion, a first electrode disposed in the first chamber, and a second electrode disposed in the second chamber. The first and second electrodes are configured to be at least partially immersed in the water, and each electrode becomes electrically charged when the electrolysis system is coupled to a current source to split the water into hydrogen and oxygen gases. The lower portion of the baffle and the first and second electrodes are each formed from the same material.

Abstract: Systems and methods for delivering medication to patients are disclosed. The system includes an infuser including a membrane. The infuser entrains a fluid from a first side of a membrane and a medication into a gas on a second side of the membrane to form a medicated humidified gas. A delivery system is coupled to the infuser. The delivery system is configured to deliver the medicated humidified gas to the patient. The method includes entraining a fluid on a first side of a membrane and a medication into a gas on a second side of the membrane to form a medicated humidified gas and delivering the medicated humidified gas to the patient using a delivery system.

Abstract: A mechanism is provided which allows transparent transaction processing to occur between distributed networks using the AIX or SNA protocols. The present invention will convert between the AIX standard of Two Phase Commit/Presumed Abort (2PC/PA) and the SNA standard of Two Phase Commit/Presume Nothing (2PC/PN). The Presumed Abort Protocol will optimize operations by reducing the number of messages between sites participating in the transaction, and the amount of transaction state information maintained at a site. Thus, any messages needed will be generated and transaction status information will be maintained in order to satisfy a Standard 2PC/PN protocol, when sites within a SNA network are participating in an AIX transaction. Further, the present invention will discard, or ignore any extraneous messages which are received while sites within an AIX network are participating in a SNA transaction.

Abstract: Apparatus and method for make up of a hemodialysis solution and supply of same to an artificial kidney; the solution optionally contains bicarbonate in any desired amount. The apparatus comprises a recirculation loop which mixes a hemodialysis dialysate concentrate with deaerated water and may include another interconnected recirculation loop adopted to form an aqueous bicarbonate solution. Both recirculation loops mix the concentrates in the recirculation fluid in venturi means operated by continuously controlling the velocity of fluid flowing therethrough to create suction to inject the requisite quantity of concentrate to form the final desired composition in the product hemodialysis solution.